Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Adrenaline (Epinephrine) 1:1,000 Solution for Injection - PA0073/035/001
- Clarithromycin 500mg Powder for Concentrate for Solution for Infusion - PA1142/022/001
- Depo-Provera 150mg/ml Suspension for Injection - PA0822/124/001
- Innohep 10,000 IU in 0.5 ml, Solution for Injection - PA0046/060/010
- Letrozole Mylan 2.5mg Film Coated Tablets - PA0577/116/001
- Navelbine 30mg Soft Capsule - PA0329/011/002
- Pinamox 125mg/5ml Powder for Oral Suspension - PA0298/010/001
- Skinoren 15% Gel - PA1025/009/001
- Telfast 180mg Film Coated Tablet - PA23180/003/003
- Temodal 180mg Capsules - EU/1/98/096/011-012
- Zacin 0.025% w/w Cream - PA1986/090/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Bendroflumethiazide 2.5mg Tablets - PA22749/021/001
- Doxatan 4mg Tablets - PA0126/202/003
- Ezetimibe Teva 10mg Tablets - PA1986/012/001
- Sabril 500mg Granules for Oral Solution - PA0540/023/002
- Tevanate Once Weekly 70mg Tablets - PA0749/016/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.